ISOgenix Limited

We are an Oxford University spin-out developing breakthrough therapies for the treatment of ALS and other neurodegenerative diseases. Our approach builds upon novel protein isoform insights identified using our state-of-the-art technologies including long read sequencing and proprietary bioinformati... Read more